Structure Other Current Assets vs Total Current Liabilities Analysis
| GPCR Stock | 55.63 0.67 1.19% |
Structure Therapeutics financial indicator trend analysis is much more than just breaking down Structure Therapeutics prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Structure Therapeutics is a good investment. Please check the relationship between Structure Therapeutics Other Current Assets and its Total Current Liabilities accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Structure Therapeutics American. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
Other Current Assets vs Total Current Liabilities
Other Current Assets vs Total Current Liabilities Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Structure Therapeutics Other Current Assets account and Total Current Liabilities. At this time, the significance of the direction appears to have very strong relationship.
The correlation between Structure Therapeutics' Other Current Assets and Total Current Liabilities is 0.88. Overlapping area represents the amount of variation of Other Current Assets that can explain the historical movement of Total Current Liabilities in the same time period over historical financial statements of Structure Therapeutics American, assuming nothing else is changed. The correlation between historical values of Structure Therapeutics' Other Current Assets and Total Current Liabilities is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Other Current Assets of Structure Therapeutics American are associated (or correlated) with its Total Current Liabilities. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Current Liabilities has no effect on the direction of Other Current Assets i.e., Structure Therapeutics' Other Current Assets and Total Current Liabilities go up and down completely randomly.
Correlation Coefficient | 0.88 |
| Relationship Direction | Positive |
| Relationship Strength | Strong |
Other Current Assets
Assets expected to be converted into cash, sold, or consumed either in one year or in the operating cycle, which are not included under standard current asset categories.Total Current Liabilities
Total Current Liabilities is an item on Structure Therapeutics balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Structure Therapeutics American are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.Most indicators from Structure Therapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Structure Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Structure Therapeutics American. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. At this time, Structure Therapeutics' Tax Provision is relatively stable compared to the past year. As of 06/07/2024, Selling General Administrative is likely to grow to about 34.3 M, while Enterprise Value Multiple is likely to drop (14.17).
| 2021 | 2022 | 2023 | 2024 (projected) | Interest Expense | 122.2K | 1.5M | 13.4M | 14.1M | Depreciation And Amortization | 72.0 | 277K | 949.2K | 996.6K |
Structure Therapeutics fundamental ratios Correlations
Click cells to compare fundamentals
Structure Therapeutics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectAdditional Tools for Structure Stock Analysis
When running Structure Therapeutics' price analysis, check to measure Structure Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Structure Therapeutics is operating at the current time. Most of Structure Therapeutics' value examination focuses on studying past and present price action to predict the probability of Structure Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Structure Therapeutics' price. Additionally, you may evaluate how the addition of Structure Therapeutics to your portfolios can decrease your overall portfolio volatility.